MedTrace Logo

Contraception in Normal and Subnormal Men

NCT00167141 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2010-02-02

No results posted yet for this study

Summary

Volunteers with normal and subnormal semen parameters receive a hormonal male contraceptive in order to investigate whether there are differences between normal and subnormal men in terms of suppressibility, rate of azoospermia and reversibility of suppression of spermatogenesis.

Conditions

  • Healthy

Interventions

DRUG

injection of hormonal male contraceptive

testosterone injections 4 times

Sponsors & Collaborators

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Eberhard Nieschlag, Prof. Dr. · Institute of Reproductive Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2007-12-31
Completion
2008-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00167141 on ClinicalTrials.gov